Precision gene delivery remains one of the greatest challenges in modern medicine. A Basel-based biopharma company, Vector BioPharma, has accepted the challenge and, with cutting-edge technology from the University of Zürich, is developing a revolutionary new way to deliver the right genes to the right place at the right time. Vector BioPharma aims to be the pioneer in delivering future medicines with this technology, now under development in multiple areas of urgent medical need.
Oxford Biomedica gains new CEO
AppointmentsDr Frank Mathias, currently CEO at Rentschler Biopharma, will join Oxford Biomedica as CEO and Board Director in March 2023.
Sino Biological Announces Construction of Its New US-Based Center for Bioprocessing
Sponsored PublicationsSino Biological, a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce the formal signing of a lease with and initiation of construction on its new Center for Bioprocessing (C4B) at its facility in Houston, Texas USA.
CatalYm GmbH raises €50m to push visugromab development
Latest NewsMunich-based immunooncology specialist CatalYm GmbH wants to use €50m from a Series C financing round to advance its anti-GDF15 antibody to Phase II development.
Cultimate Foods UG raises €700.000 in pre-seed financing
Latest NewsCellular agriculture company Cultimate Foods UG has got a pre-seed funding led by Big Idea Ventures, ProVeg International and Realum.cloud.
Cradle BV bags €5.4m in seed financing
Latest NewsBiotech start-up Cradle BV has raised €5.4m in seed financing to design cell-factories with AI and scale bioprocesses much faster and cheaper.
Vector BioPharma: the future of gene delivery
BackgroundPrecision gene delivery remains one of the greatest challenges in modern medicine. A Basel-based biopharma company, Vector BioPharma, has accepted the challenge and, with cutting-edge technology from the University of Zürich, is developing a revolutionary new way to deliver the right genes to the right place at the right time. Vector BioPharma aims to be the pioneer in delivering future medicines with this technology, now under development in multiple areas of urgent medical need.
Standing Ovation inks exlusive partnership with Bel Group
Latest NewsMicrobial casein maker Standing Ovation SA has inked an exklusive collaboration with Bel Group, one of France’s biggest cheese-makers to bring its vegan cheese to the market.
EpiEndo Pharmaceuticals pushes COPD candidate
Latest NewsEpiEndo Pharmaceuticals ehf got the green light for a Phase IIa COPD trial with its non-anbibiotic macrolide EP395
Novo Nordisk Foundation funds Plant2Food with €27m
Latest NewsDanish Novo Nordisk Foundation has invested in Plant2Food, a new open innovation hub for researchers and companies to develop plant-based foods.
OxSonics Therapeutics with new Chief Executive Officer
AppointmentsAt the beginning of november, OxSonics Therapeutics has appointed Jérôme Marzinski as its Chief Executive Officer.